← Open Payments lookup

AMBER SENATOR: Open Payments

NPI 1558863597 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,756 in 61 payments from 17 companies in 2025. Trend: 2023 $2,449 · 2024 $3,588 · 2025 $1,756

Food & beverage: $1,756
CompanyPaymentsAmount
Janssen Biotech, Inc.15$468
ABBVIE INC.14$230
Takeda Pharmaceuticals U.S.A., Inc.7$179
Mallinckrodt Hospital Products Inc.1$145
AstraZeneca Pharmaceuticals LP1$127
GENZYME CORPORATION1$119
Madrigal Pharmaceuticals3$100
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$59
Gilead Sciences, Inc.3$58
PFIZER INC.3$55

Products named: TREMFYA, TERLIVAZ, DUPIXENT, DATROWAY, MAVYRET, REZDIFFRA, XELJANZ, IQIRVO.

Industry payments across AZ — which companies pay providers there.